Amp-Seq One, a new one-step targeted GBS workflow is launching in 2025.

For early access and to find out more
 

Redefining simplicity in targeted sequencing

Amp-Seq is a mid-plex targeted genotyping by sequencing workflow for agricultural biotechnology genotyping on an industrial scale. The patent pending Amp-Seq technology focuses on workflow simplicity paired with automatability, fastest processing time and unparalleled cost effectiveness. Amp-Seq delivers a solution that enables in-house genotyping on an unprecedented scale.

Key benefits

  • Performance - High design success rates and SNP call rates*
  • Simple, easy to adopt workflow. See figure 1 on the workflow tab.
    • Simple and user friendly protocol
    • Minimises impact of user errors
    • Low number of reaction components
  • Cost effective
    • Reducing sequencing costs up to 50%*
    • Reducing labour costs by minimising hands-on time*
    • Low reagent costs and ultra-low reactions volumes*
  • Increased throughput and reduced turnaround time by up to 30%*
    • Industry leading protocol turnaround time - up to 1.8X faster*
    • Same-day-sequencing
    • Pool of thousands of samples and target up to 5,000 markers per sample
    • Compatibility with undiluted crude input material*
  • Reduced environmental impact with ambient temperature stable components
    • Reduce dry ice usage, CO2 emissions and shipping costs  
    • Reduced energy consumption and freezer space requirements 
  • Confidence in supply
    - LGC Biosearch Technologies manufactured reagents
    - Extensive on- and off-site local support resources
    - High-quality standards and manufacturing accreditations
     

* Validated against the targeted sequencing technologies most prevalently used in the agricultural biotechnology industry. Review the Amp-Seq application note for full details.